Brief: Virogates Expects 2026 EBIT Loss Of DKK 10 Mln-12 Mln

ViroGates A/S

12/12/2025 10:38

Dec 12 (Reuters) - ViroGates A/S VIROG.CO:

EXPECTS FULL-YEAR REVENUE BETWEEN DKK 6 AND 7 MILLION AND AN EBIT OF DKK -10 TO -12 MILLION IN 2026.

CONTINUES TO PAUSE ITS GUIDANCE TO MARKET REGARDING ACHIEVING POSITIVE CASH FLOW

ENTERING 2026, VIROGATES EXPECTS TO HAVE COMPLETED MOST OF FUNDED ANALYTICAL WORK RELATED TO COLLABORATION WITH SOBI AIMED AT OBTAINING U.S. MARKETING CLEARANCE FOR SUPARNOSTIC® TURBILATEX

CONTINUES TO PROGRESS TOWARDS AN IVDR CLEARANCE OF ITS PRODUCTS

Source text: ID:nMFN6hpR2r

Further company coverage: VIROG.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))